CLEC7A binds 1,3-beta-D-glucan

Stable Identifier
Reaction [binding]
Homo sapiens
Dectin-1 binds 1,3-beta-D-glucan
Locations in the PathwayBrowser
SVG |   | PPTX  | SBGN
Click the image above or here to open this reaction in the Pathway Browser
The layout of this reaction may differ from that in the pathway view due to the constraints in pathway layout

CLEC7A (Dectin-1) was identified as a primary receptor for beta-glucans from fungi, bacteria, and plants and specifically recognises beta 1-3 linked glucans. Human CLEC7A has eight alternatively splice products of which only two are functional for beta-glucan binding (isoforms A and B) (Willment et al. 2001). CLEC7A possesses an extracellular C-type lectin-like domain (CTLD) that is connected by a stalk region to a transmembrane domain and cytoplasmic tail, which contains an immunoreceptor tyrosine-based activation (ITAM)-like motif. Two highly conserved amino acids (222W 224H in Human; 221W, 223H in Mouse) within the CTLD which have been identified as essential for beta-glucan binding (Brown et al. 2007, Adachi et al. 2004). Through the recognition of beta-glucans, CLEC7A binds several fungal species such as Aspergillus, Candida, Coccidioides, Pencillium, Pneumocystis and Saccharimyces.
Ferwerda et al. (2009) suggest that chronic mucocutaneous candidiasis may be caused by a genetic defect of CLEC7A. The mutation of nucleotide A-->C causes a change of amino acid 238 from tyrosine to a stop codon (Tyr238*), leading to the loss of the last nine amino acids of the carbohydrate-recognition domain (CRD). This mutated form of CLEC7A is poorly expressed and does not mediate beta-glucan binding, leading to defective production of cytokines after stimulation with beta-glucans or Candida albicans (Ferwerda et al. 2009).

Inferred From
Cite Us!